Neonc Technologies
NTHI | NASDAQ
$4.54
-$0.37 (-7.54%)
At close: Nov 16, 2026, 4:00 PM ET
$4.47
-$0.07 (-1.54%)
After-hours:
Nov 16, 2026, 7:57 PM ET
-7.54%
(1D)No price chart data available for 1D timeframe.
Rating
44.5
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #406/1021 (Top 40%)
Key Statistics
Market Data
Market Cap $130.98M
1D Range
4.51 5.44
52W Range
2.53 10.75
Valuation (TTM)
PE -2.21
PB -9.94
EV/EBITDA -3.00
Valuation (NTM)
Forward PE N/A
Forward PEG 0.04
Price Target $16.50
Cash Flow
FCF Yield -15.6%
SBC Adj. FCF Yield -29.5%
SBC Impact -89.3%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y N/A |
N/A
FCF 3Y | 5Y N/A |
N/A
Returns
ROA -462.4%
ROE 349.3%
ROIC 316.1%
Financial Health
Net Cash
$5.86M
Current Ratio 0.38
Interest Coverage -18.88
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company. It develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central ne...
Sector Healthcare
Industry Biotechnology
Employees 5
IPO Date Mar 26, 2025
Website www.neonctech.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
1
Consensus
Buy
Price Target
$16.50
Upside
+263.44%
Buy (1)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove NTHI